Hemant Surgical Industries P/E Ratio
Current P/E Ratio
48.6
High Valuation
Very High - High growth expectations or significantly overvalued
Hemant Surgical Industries (HSIL) P/E ratio is 48.6 (High), EPS (TTM) ₹7.70, current price ₹ on None — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Hemant Surgical Industries share price today.
Current Valuation Metrics
P/E Ratio
48.6
Current Price
₹
EPS (TTM)
₹7.70
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.69
Sector Median
27.43
Sector Rank
#11 of 192
Sector Percentile
5.7%
HSIL P/E Ratio — Valuation Signal & Historical Context
Hemant Surgical Industries P/E 48.6 — signal: Overvalued. Analyse Hemant Surgical Industries ownership pattern to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 48.6, suggesting caution for new investments
HSIL vs Healthcare Peers — P/E Ratio Comparison
Hemant Surgical Industries P/E 48.6 vs Healthcare average 53.69, median 27.43 — range 1.03–1007.14.
Sector Average
53.69
Sector Median
27.43
Lowest P/E
1.03
Highest P/E
1007.14
Companies
192
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.03 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 4.19 | ₹71 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.7 | ₹1,105 | Low |
| Amwill Health Care | AMWILL | 6.71 | ₹71 | Low |
| Shelter Pharma | SHELTER | 6.75 | ₹49 | Low |
| Mono Pharmacare | MONOPHARMA | 7.44 | ₹23 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹68 | Low |
| Par Drugs & Chemical | PAR | 8.09 | ₹113 | Low |
| Galaxy Medicare | GML | 8.65 | ₹29 | Low |